Tempus AI, Bristol Myers Sign Multi-Year Oncology Data and AI Deals
Tempus AI will license oncological data to Bristol Myers Squibb and provide access to its Lens platform under a multi-year agreement.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.